Calvo, A., Alonso, S., Prieto, E., Ascaso del Río, A., Ortuño, J., Fernández, N., & Portolés Pérez, A. (2022). Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers.
Citación estilo ChicagoCalvo, Aitana, Saioa Alonso, Esther Prieto, Ana Ascaso del Río, Jordi Ortuño, Nieves Fernández, y Antonio Portolés Pérez. Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers. 2022.
Cita MLACalvo, Aitana, et al. Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers. 2022.